Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome

David M. Safley, Steven P. Marso

Research output: Contribution to journalReview article

5 Scopus citations


Diabetes mellitus has reached epidemic proportions worldwide. Patients with diabetes are at increased risk for acute coronary syndromes, and these syndromes lead to frequent morbidity and cardiovascular mortality. Emerging adjunctive pharmacological strategies coupled with the drug-eluting stent platform have resulted in improved adverse event rates for this high-risk group. This review will concentrate on the historical data associated with acute coronary syndromes in diabetes mellitus, focusing on revascularisation, drug-eluting stents and antiplatelet therapies.

Original languageEnglish (US)
Pages (from-to)128-135
Number of pages8
JournalDiabetes and Vascular Disease Research
Issue number3
StatePublished - Oct 2005



  • Acute coronary syndromes
  • Antiplatelet therapy
  • Diabetes
  • Drug-eluting stents
  • Percutaneous coronary intervention

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this